Evotec AG (NASDAQ:EVTCY) | Finanzwire

Basculer en Français

11243	Companies
249450	Keywords
177488	Articles
135239	Press releases

Home
Companies
Evotec AG

BRIEF

published on 10/15/2026 at 07:35, 13 days 7 hours ago

Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer

Biotechnology Drug Discovery Evotec Joanna Holbrook Scientific Strategy
PRESS RELEASE

published on 10/15/2026 at 07:30, 13 days 7 hours ago

Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board
Evotec appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board. Dr. Holbrook brings 25+ years experience in pharma, biotech, and academia

Chief Scientific Officer Management Board Evotec Pharma Dr. Joanna Holbrook
BRIEF

published on 10/13/2026 at 22:42, 14 days 16 hours ago

Evotec Reports Nine-Month 2026 Results Surpassing Expectations

Biotechnology Financial Guidance Nine-month Results Evotec 2026 Preliminary Revenues
PRESS RELEASE

published on 10/13/2026 at 22:37, 14 days 16 hours ago

EQS-Adhoc: Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance
Evotec SE announces preliminary nine-months 2026 results above market expectations, reaffirms full-year 2026 guidance. Full financial results will be published on November 5, 2026

Evotec SE Preliminary Results Financial Forecast Market Expectations Full-year Guidance
BRIEF

published on 09/29/2026 at 07:35, 29 days 7 hours ago

Evotec Announces Transition of Chief Scientific Officer

Drug Discovery Evotec SE Leadership Transition Scientific Innovation IPSC Technologies
PRESS RELEASE

published on 09/29/2026 at 07:30, 29 days 7 hours ago

Evotec Announces Chief Scientific Officer Transition
Evotec SE announces the transition of Chief Scientific Officer Dr. Cord Dohrmann, effective September 30, 2026. The search for a successor is ongoing

Chief Scientific Officer Evotec SE Biotech Transition Search Ongoing
BRIEF

published on 09/09/2026 at 07:35, 1 month 19 days ago

Evotec Advances Antibodies Against Orthopoxvirus to Clinical Trials

Phase 1 Clinical Trial Evotec SE Orthopoxvirus Monoclonal Antibodies Biodefense Preparedness
PRESS RELEASE

published on 09/09/2026 at 07:30, 1 month 19 days ago

Just – Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
Just \/ Evotec Biologics advances investigational antibodies against orthopoxviruses into Phase 1 clinical studies under U.S. Department of War Accelerated Antibodies Program, supporting biodefense preparedness

Biodefense U.S. Department Of War Orthopoxviruses Just \/ Evotec Biologics Phase 1 Clinical Studies
BRIEF

published on 09/02/2026 at 07:35, 1 month 26 days ago

Evotec and Plectonic Collaborate on T-Cell Approaches for Solid Tumors

Evotec SE Solid Tumors Immunotherapy Plectonic Biotech T-cell Engagement
PRESS RELEASE

published on 09/02/2026 at 07:30, 1 month 26 days ago

Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors
Evotec SE and Plectonic Biotech collaborate on a new T-cell-engaging immunotherapy approach for solid tumors, combining BiTco costimulatory platform with LOGIBODY technology

Evotec SE Solid Tumors Immunotherapy Plectonic Biotech T-cell-engaging

Accesswire

Published on 10/28/2026 at 12:30, 2 hours 49 minutes ago

Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 2 hours 49 minutes ago

AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 2 hours 49 minutes ago

Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out
Published on 10/28/2026 at 12:30, 2 hours 49 minutes ago

Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq
Published on 10/28/2026 at 12:15, 3 hours 4 minutes ago

BULGOLD Expands Strategic Exploration Position Around the Lutila Gold Project with Two New Exploration Licences

View all ACCESSWIRE

EQS Group

Published on 10/28/2026 at 15:08, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bodycote PLC
Published on 10/28/2026 at 14:00, 1 hour 19 minutes ago

Original-Research: BASF SE (von Parmantier & Cie. GmbH): Buy
Published on 10/28/2026 at 14:00, 1 hour 19 minutes ago

Eckert & Ziegler Receives GMP Certificate for Actinium-225
Published on 10/28/2026 at 13:33, 1 hour 46 minutes ago

ADS-TEC Energy Advances One of Europe’s Largest Battery Storage Projects as Building Permit Nears
Published on 10/28/2026 at 13:20, 1 hour 59 minutes ago

Clearway Capital rejects GZO's portrayal of the settlement with Steiner / H56 Immo

Les Echos

Published on 10/28/2026 at 08:00, 7 hours 19 minutes ago

Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/27/2026 at 18:00, 21 hours 19 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 17:59, 21 hours 20 minutes ago

Q3 2026 sales
Published on 10/27/2026 at 17:45, 21 hours 34 minutes ago

Haulotte - 2026 Q3 Sales
Published on 10/27/2026 at 17:45, 21 hours 34 minutes ago

First contract signed in Belgium for the construction of a 170 MW / 340 MWh battery energy storage system (BESS), in a temporary consortium with Eiffage Énergie Systèmes

View all LES ECHOS COMFI WIRE